MB, Levis & Associates’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Hold |
1,481
| – | – | 0.05% | 86 |
|
|
2025
Q1 | $109K | Buy |
1,481
+21
| +1% | +$1.54K | 0.05% | 82 |
|
|
2024
Q4 | $95.7K | Hold |
1,460
| – | – | 0.05% | 88 |
|
|
2024
Q3 | $114K | Buy |
1,460
+9
| +0.6% | +$701 | 0.06% | 78 |
|
|
2024
Q2 | $113K | Hold |
1,451
| – | – | 0.06% | 78 |
|
|
2024
Q1 | $98.3K | Buy |
1,451
+21
| +1% | +$1.42K | 0.05% | 86 |
|
|
2023
Q4 | $96.3K | Hold |
1,430
| – | – | 0.06% | 83 |
|
|
2023
Q3 | $96.8K | Buy |
1,430
+10
| +0.7% | +$677 | 0.06% | 81 |
|
|
2023
Q2 | $102K | Hold |
1,420
| – | – | 0.07% | 81 |
|
|
2023
Q1 | $98.6K | Buy |
1,420
+20
| +1% | +$1.39K | 0.07% | 80 |
|
|
2022
Q4 | $94.9K | Buy |
+1,400
| New | +$94.9K | 0.07% | 76 |
|